Product Code: RP-ID-10352071 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Industrial Automation & Equipment |
Report ID: 10352071
Market Overview:
Global Amniocentesis Needles Market Analysis & Outlook 2030
The global amniocentesis needles market is anticipated to expand at a CAGR of 3% over the period 2022-2030 with the revenue estimated to be USD 160 million in 2021. The amniocentesis needles market is expected to grow in the coming years due to factors such as increasing pregnancy rates, increasing preference for minimally invasive and non-invasive diagnostic methods, and increasing use of diagnostic tests in developed countries. Also called amniocentesis or AFT. Amniocentesis is done to diagnose chromosomal abnormalities and infections in the fetus. It can also be used to determine gender. An amniocentesis needle is used to aspirate amniotic fluid. Amniocentesis needles are sterile and disposable. The needle tip is spirally etched to provide a sharp ultrasound image. To aspirate amniotic fluid, an amniocentesis needle is inserted into the amniotic membrane away from the fetus and placenta.
Analyzing COVID-19 Scenarios:
There is a growing demand for medical devices that treat patients. Medical devices widely used in primary care include respiratory devices such as nebulizers, survival devices, oxygen generators, and monitors. The COVID-19 pandemic is also increasing the demand for medical devices such as personal protective equipment such as masks, gloves and eye protection. As COVID-19 cases increase worldwide, the need for medical devices for preventive measures by healthcare professionals and the general public continues to grow. Manufacturers of these products have the opportunity to capitalize on this growing demand for medical devices to ensure an adequate and continuous supply of personal protective equipment in the market. Due to these factors, COVID-19 is expected to have a significant impact on the needles market for amniotic centers.
Key Influencing Factors:
Factors such as increasing pregnancies and preference for minimally invasive and non-invasive diagnostic methods are expected to drive the amniocentesis needles market. The success of amniotic puncture has led to the growth of the amniotic needle market owing to the growth of the amniotic needle market, technological advances in amniotic procedures, and the average age of first trimester, however, harm to the fetus and competition have arisen. Between the big companies and the cost. The high level of this method will impede the market growth in several ways over the next few years, and the lack of knowledge about amniocentesis technology and lack of diagnostic equipment may hamper the growth of amniocentesis. Needle market in the forecast period.
New Product Launch / News:
In April 2019, Boryang Biopharma launched Mom Scanning Plus, a non-invasive prenatal test from local company Cancer Rope that uses molecular diagnostics to detect hereditary disorders. This study uses the G-Scanning Plus database, a tool capable of detecting developmental disorders in newborns through genetic analysis and identifying diseases that overlap with more than 100 microgen deletions. In 2018, Medline Industries, Inc. (USA) acquired Centurion Medical Products (USA) to increase the importance of strengthening its Pregnancy Kits, Minor Surgical Aid Kits and Infection Prevention businesses. In June 2018, Getting launched a new version of the Flow-C anesthesia machine. It is designed to accelerate and simplify the routine anesthesia workflow in the operating room. The easy-to-use touch screen controls all functions from a single point, and the ease of use of the system saves staff and increases flexibility in the operating room. This product offering expanded the companys product portfolio and increased its market share.
Related Reports
Proof of Quality & Reliability
